<p>TB and rifampicin resistant-TB cases detected and initiated on treatment by each of the 4 diagnostic strategies, in a cohort 100,000 persons.</p
1<p>Newly diagnosed cases.</p>2<p>Patient received >1 month of anti TB drug therapy.</p>3<p>Multidru...
Multidrug-resistant tuberculosis (MDR-TB) is resistant to both rifampicin (RIF) and isoniazid (INH)....
Objectives. To investigate the factors associated with rifampicin-resistant tuberculosis among drug ...
<p><i>Abbreviations—OR = Odds Ratio</i>, <i>CI = Confidence interval</i></p><p>Rifampicin resistant ...
Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often...
BACKGROUND Globally 3.9% of new and 21% of re-treatment tuberculosis (TB) cases are multidrug-resist...
BACKGROUND Globally 3.9% of new and 21% of re-treatment tuberculosis (TB) cases are multidrug-resist...
The World Health Organization (WHO) defines multidrug-resistant tuberculosis (MDR-TB) as resistance ...
Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often...
Planning for tuberculosis (TB) control requires an assessment of the number and distribution of drug...
Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often...
BACKGROUND: Globally 3.9% of new and 21% of re-treatment tuberculosis (TB) cases are multidrug-resis...
Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.</p
R-res; Rifampicin Resistance. TAF-I; Treatment after Failure Category I. TAF-II; Treatment after Fai...
Values in the bars indicate number (percentages). *12 of 118 with a failed result were imputed as Xp...
1<p>Newly diagnosed cases.</p>2<p>Patient received >1 month of anti TB drug therapy.</p>3<p>Multidru...
Multidrug-resistant tuberculosis (MDR-TB) is resistant to both rifampicin (RIF) and isoniazid (INH)....
Objectives. To investigate the factors associated with rifampicin-resistant tuberculosis among drug ...
<p><i>Abbreviations—OR = Odds Ratio</i>, <i>CI = Confidence interval</i></p><p>Rifampicin resistant ...
Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often...
BACKGROUND Globally 3.9% of new and 21% of re-treatment tuberculosis (TB) cases are multidrug-resist...
BACKGROUND Globally 3.9% of new and 21% of re-treatment tuberculosis (TB) cases are multidrug-resist...
The World Health Organization (WHO) defines multidrug-resistant tuberculosis (MDR-TB) as resistance ...
Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often...
Planning for tuberculosis (TB) control requires an assessment of the number and distribution of drug...
Multi-drug resistant tuberculosis (MDR-TB) is a major public health concern since diagnosis is often...
BACKGROUND: Globally 3.9% of new and 21% of re-treatment tuberculosis (TB) cases are multidrug-resis...
Sputum culture and phenotypic drug resistance of 243 Xpert rifampicin-resistant TB patients.</p
R-res; Rifampicin Resistance. TAF-I; Treatment after Failure Category I. TAF-II; Treatment after Fai...
Values in the bars indicate number (percentages). *12 of 118 with a failed result were imputed as Xp...
1<p>Newly diagnosed cases.</p>2<p>Patient received >1 month of anti TB drug therapy.</p>3<p>Multidru...
Multidrug-resistant tuberculosis (MDR-TB) is resistant to both rifampicin (RIF) and isoniazid (INH)....
Objectives. To investigate the factors associated with rifampicin-resistant tuberculosis among drug ...